menu search

Jubilee metals ceo talks progress and prospects - icymi

In conversation with Thomas Warner from Proactive, Leon Coetzer, CEO of Jubilee Metals Group PLC (AIM:J...

November 4, 2023, 6:38 am

The lonely bull on the planet: carvana's transformation of the marketplace model (rating upgrade)

Carvana's stock price jumped 15% following its third quarter earnings release, driven by improved profitability and cost control. The company's wholes...

November 4, 2023, 6:21 am

Chewy: pharmacy remains a big opportunity, but stock looks fairly valued

Chewy's autoship program is a major strength, with 75.5% of sales coming from autoship customers. The c...

November 4, 2023, 6:19 am

Moncler: a great opportunity in the luxury sector

Moncler has the potential to establish itself as a leading luxury brand through its marketing, history, and customer experience. The company's transit...

November 4, 2023, 6:04 am

Kefi gold and copper: a comprehensive update on operational progress and market dynamics - icymi

In this interview, Thomas Warner from Proactive chats with Harry Anagnostaras-Adams, the executive cha...

November 4, 2023, 5:29 am

Michael saylor: with institutional interest shifting to bitcoin, ‘we 10x from here’

As Wall Street firms turn their attention to bitcoin, the MicroStrategy chairman believes exponential growth is next. Read Full Story The post Michael...

November 4, 2023, 2:59 am

Metals-copper prices gain as weaker dollar offsets rising stocks

By Polina Devitt LONDON, Nov 3 (Reuters) – Copper prices rose in London on Friday as the dollar continued to weaken after U.S. jobs data, offsetting...

November 4, 2023, 1:29 am

Closing bell: rbc quant us equity leaders cad heg etf up on tuesday (rueh)

In trading today, RBC Quant US Equity Leaders CAD Heg ETF stock opened at $36.38 and closed at $36.38. prices ranged...

November 4, 2023, 1:14 am

Rosen, a globally recognized law firm, encourages waldencast plc investors to inquire about securities class action investigation – wald, waldw

NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities cla...

November 4, 2023, 1:08 am

Closing bell: ci gold bullion fund etf hg cad flat on wednesday (valt)

Today, CI Gold Bullion Fund ETF Hg CAD shares closed at $24.75 after opening the day at $24.75. It traded at a low of $24.75 to a high of $24.75. The ...

November 4, 2023, 12:29 am

Seacor marine: good company, but not good enough

The OSV market is expected to face a deficit due to low order book levels and declining shipyard capacity, but growing demand...

November 4, 2023, 12:05 am

South korea's exports rebound in october 2023

South Korea's exports to mainland China have remained weak during 2023, recording a decline of 9.5% y/y in October. According to latest trade data...

November 4, 2023, 12:04 am

Closing bell: rbc us banks yield cad hgd index etf up on thursday (rubh)

In today’s trading, RBC US Banks Yield CAD Hgd Index ETF shares closed at $12.35 after opening the day at $12.27. Intraday prices ranged...

November 3, 2023, 11:44 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Correction: national youth prevention summit highlights colorado campaign to protect teens from fentanyl

This release has been corrected to identify the source as SE2 Denver, Colo., Nov. 03, 2023 (GLOBE NEWSWIRE) — A national youth prevention summit org...

November 3, 2023, 11:10 pm

China: policymakers committed to supporting growth

A surprising mid-year budget revision from policymakers in China was recently approved, widening the bu...

November 3, 2023, 10:45 pm

Gold price analysis: paddling just beneath $2,000

Spot Gold has been trading on the top side of the 200-day SMA currently grinding towards $1,940, and Friday’s knock back...

November 3, 2023, 10:44 pm


Search within

Pages Search Results: